Conversely, IL-33 is a detrimental factor in other settings, such during autoantibody-induced arthritis (26–29), eosinophilic asthma (8, 9), cancer (30, 31), early-stage colitis (32), and lung fibrosis (11). The gene discussed is IL33; the disease is cancer.